Common blood pressure medicine blocks molecule that can trigger the disease
A drug commonly used to control high blood pressure may also help prevent the onset of Type 1 diabetes in up to 60 percent of those at risk for the disease, according to researchers at the University of Colorado Anschutz Medical Campus and the University of Florida (UF) in Gainesville.
The study was published online this week in the Journal of Clinical Investigation.
“This is the first personalized treatment for Type 1 diabetes prevention,” said Aaron Michels, MD, a researcher at the Barbara Davis Center for Childhood Diabetes and associate professor of medicine at CU Anschutz. “We made this discovery using a supercomputer, on the lab bench, in mice and in humans.”
The drug, methyldopa, has been used for over 50 years to treat high blood pressure in pregnant women and children. It is on the World Health Organization’s list of essential drugs.
But like many drugs used for one condition, Michels and his colleagues found it useful for something totally unrelated.
Some 60 percent of people at risk of getting Type 1 diabetes possess the DQ8 molecule which significantly increases the chance of getting the disease. The researchers believed that if they could block specifically the DQ8 molecule they could also block the onset of the disease.
“All drugs have off-target effects. If you take too much acetaminophen you can hurt your liver,” Michels said. “We took every FDA-approved small molecule drug and analyzed HLA-DQ8 binding through a supercomputer. We searched a thousand orientations for each drug to identify those that would fit within the DQ8 molecule binding groove.”
After running thousands of drugs through the supercomputer, they found that methyldopa not only blocked DQ8, but it didn’t harm the immune function of other cells like many immunosuppressant drugs do.
The research spanned 10 years and its efficacy was shown in mice and in 20 Type 1 diabetes patients who took part in a clinical trial at the Barbara Davis Center at the University of Colorado School of Medicine.
“We can now predict with almost 100 percent accuracy who is likely to get Type 1 diabetes,” Michels said. “The goal with this drug is to delay or prevent the onset of the disease among those at risk.”
The drug is taken orally, three times a day.
Implications for treatment
Michels and UF Health researcher David Ostrov, PhD, hope this same approach of blocking specific molecules can be used in other diseases.
“This study has significant implications for treatment of diabetes and also other autoimmune diseases,” said Ostrov, associate professor of pathology, immunology and laboratory medicine in the UF College of Medicine and a member of the UF Health Cancer Center, Genetics Institute and Center for NeuroGenetics. “This study suggests that the same approach may be adapted to prevent autoimmune diseases such as rheumatoid arthritis, coeliac disease, multiple sclerosis, systemic lupus erythematosus and others.”
The next step will be a larger clinical trial sponsored by the National Institutes of Health in spring.
“With this drug, we can potentially prevent up to 60 percent of Type 1 diabetes in those at risk for the disease,” Michels said. “This is very significant development.”
The Latest on: Type 1 diabetes
via Google News
The Latest on: Type 1 diabetes
- Smart Meter's iGlucose Cellular Diabetes Care Solution Demonstrated to Help High Risk Patients on February 19, 2019 at 9:40 am
... the United States and other countries have shown that controlling blood glucose benefits people with either type 1 or type 2 diabetes. Overall, for every 1.0-point reduction in A1C, the risk of de... […]
- Data highlight opportunities to diagnose type 1 diabetes before DKA onset on February 19, 2019 at 9:01 am
medwireNews: Children with type 1 diabetes are more likely than their non-diabetic peers to seek primary care for a number of specific conditions in the year before their diagnosis, which could aid de... […]
- Higher heart rates related to type 2 diabetes risk in normal-weight adults on February 19, 2019 at 8:01 am
The researchers found that heart rate was correlated with type 2 diabetes incidence, as those with heart rates of more than 86 beats per minute (bpm; HR = 1.49; 95% CI, 1.28-1.74), 80 bpm to 86 bpm (H... […]
- Bret Michaels on living with diabetes: ‘It’s supposed to be a curse. It ends up being a blessing in some strange way’ on February 19, 2019 at 7:20 am
But for Michaels, who has type 1 diabetes, finding that balance can be a matter of life and death. “Diabetes is a very complicated disease,” Michaels tells Yahoo Lifestyle. “When you’re diabetic, ther... […]
- I've Been Diagnosed With Gestational Diabetes. Now What? on February 19, 2019 at 7:12 am
... you use – but there’s going to be some women who actually have Type 2 diabetes, and even Type 1 diabetes, that is only picked up during pregnancy,” Seely points out. What’s more ... […]
- Human genes used in type 1 diabetes mouse research could improve search for a cure on February 19, 2019 at 6:27 am
The development and progression of type 1 diabetes has been successfully replicated in mice, which could help researchers understand more about the condition. The study carried out by a Spanish team i... […]
- Charlyn Fargo Ware: Understanding Type 3 Diabetes on February 18, 2019 at 3:09 pm
You’ve probably heard of Type 1 diabetes (mainly in children) and Type 2 diabetes (which occurs later in life), but now there is a Type 3 diabetes. It’s the result of a link between diabetes and Alzhe... […]
- How Mason Greer, son of a former Ranger, used his Type 1 diabetes diagnosis to become a role model on February 17, 2019 at 6:49 pm
KELLER -- Coiled up in more layers than an onion, one of the most popular players in Rangers history is nearly indistinguishable from the other Colleyville Heritage dads decorating cold bleachers ... […]
- Functioning Beta Cells Survive in Type 1 Diabetes on February 15, 2019 at 4:18 pm
There is more going on than just the immune system attacking. Type 1 diabetes is a disease in which the patient’s immune system is known to destroy the body’s own beta cells. But a previous study has ... […]
via Bing News